Some days, this blog just writes itself. Today is one of them, per the WSJ Health Blog:. . . .Ever since Merck announced it was taking over rival Schering-Plough, inquiring minds have wanted to know: What will Schering-Plough CEO Fred Hassan do next?
Perhaps now we have a clue: Hassan is joining us bloggers, at least for some of his time.
In a Huffington Post piece, Hassan weighed in yesterday on the health-care debate, arguing that the discussion has unwisely ignored serious and long-term threats such as Alzheimer’s disease. . . .
The deal for the very-life of his company hangs in the balance. . . and he is off, blogging? Cool. I can FINALLY relate.
Credit for the original work on the fabulous graphic, at right, goes to "The Insider" PharmaGossip.
Overall, though -- sometimes, the truth is far stranger than anything we could make up. . . . This is one of those times, for dead certain (Kudos to The Insider!):
So where's the theme music?
ReplyDeleteYou should have it play every time someone opens SGP until you have to put this one in the archives.
Salmon
Great Idea -- When home tonight, I can rig up an mp3 file to play. . . .
ReplyDeleteMournful, somber. . . sinister!
Namaste
Senate hearings on CME focused on Schmerck today
ReplyDeletehttp://pharmalittle.blogspot.com/2009/09/selling-vyto.html
Salmon
Thanks, Salmon --
ReplyDelete[I almost forgot about pharmalittle -- an unwise move, to be sure!] Now, CardioBrief certainly did -- but the hearings were held on July 29, 2009 -- and the Senate Special Committee on Aging hasn't made the full Report from that session (which contains the figures the WSJ and CardioBrief have discussed) available in electronic format, yet.
I suspect it will be used as preemptive press material, once the fight for Baucus' Plan intensifies. I still haven't secured the press credentials needed to gain the special access the WSJ and CardioBrief enjoy -- to immediate paper records.
Namaste
http://www.youtube.com/watch?v=hkTQdEZbjQA
ReplyDelete